Drug Resistance in Tuberculosis and Its Public Health Management ...
Drug Resistance in Tuberculosis and Its Public Health Management ...
Drug Resistance in Tuberculosis and Its Public Health Management ...
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Drug</strong> <strong>Resistance</strong> <strong>in</strong> <strong>Tuberculosis</strong><strong>and</strong> <strong>Its</strong> <strong>Public</strong> <strong>Health</strong> <strong>Management</strong>Dr. Paul NunnWhy is plann<strong>in</strong>g for MDR-TBtreatment programmes important?• MDR-TB treatment is difficult, complex, time-consum<strong>in</strong>g<strong>and</strong> expensive – much more so than drug sensitive TB• Provision of reliable treatment to hundreds of patientsfor ~2 years on a national scale requires enormouscoord<strong>in</strong>ation of multiple players – <strong>and</strong> is thus a majorplann<strong>in</strong>g exercise25http://www.path.org/publications/detail.php?i=1678Essential pr<strong>in</strong>ciples of care for MDR-TBstrengthen basic TB controlPolitical commitment to implement objectives of the responsewith adequate budget to startMicrobiological diagnosis (culture, drug susceptibility test by a qualityassuredlaboratory) <strong>and</strong> monitor<strong>in</strong>g of response to treatmentCollaboration with HIV programmePatient-centred approach for direct observation of treatmenton out-patient or hospitalised basisCare under proper <strong>in</strong>fection control conditions26Quality assured second-l<strong>in</strong>e anti-TB drugs, meet<strong>in</strong>g at leastWHO-GMP st<strong>and</strong>ardsRecord<strong>in</strong>g <strong>and</strong> report<strong>in</strong>g for monitor<strong>in</strong>g <strong>and</strong> evaluationEssential elements <strong>in</strong> plann<strong>in</strong>g the strengthen<strong>in</strong>gof basic TB control through MDR-TB managementEstimate burdenMeasure diagnostic capacity <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsDecide models of care (hospitalisation, outpatient)Ensure <strong>in</strong>fection control measures <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsEnsure social support networkPlan drug procurement – second-l<strong>in</strong>e anti-TB drugs <strong>and</strong> those for adverse effectsSet up record<strong>in</strong>g <strong>and</strong> report<strong>in</strong>g systemEnsure workforce <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsSet up staff development <strong>and</strong> tra<strong>in</strong><strong>in</strong>gWrite national guidel<strong>in</strong>es <strong>and</strong> manual of operationsConsider operational research agendaBudget <strong>and</strong> f<strong>in</strong>anc<strong>in</strong>g27The screen versions of these slides have full details of copyright <strong>and</strong> acknowledgements9